Oxygen administration in the care of neonates: A double-edged sword

Chinese Medical Journal

Volumn 123, Issue 20, 2010, Pages 2938-2942

  Dennery, Phyllis A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Bronchopulmonary dysplasia; Prematurity; Retinopathy of prematurity; Supplemental oxygen

Indexed keywords

ANTIOXIDANT; REACTIVE OXYGEN METABOLITE; OXYGEN;

CEREBRAL PALSY; CHILDHOOD CANCER; DATA BASE; EMBRYO DEVELOPMENT; HUMAN; HYPEROXIA; LUNG DYSPLASIA; NEWBORN; OXYGEN THERAPY; OXYGEN TOXICITY; PULMONARY HYPERTENSION; RESPIRATION CONTROL; RESUSCITATION; RETROLENTAL FIBROPLASIA; REVIEW; ANIMAL; NEWBORN DISEASE; PRACTICE GUIDELINE; PREMATURITY;

ANIMALS; EMBRYONIC DEVELOPMENT; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INFANT, PREMATURE; OXYGEN; PRACTICE GUIDELINES AS TOPIC; RETINOPATHY OF PREMATURITY;

EID: 79952276307     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2010.20.034     Document Type: Review

References (48)

1. Severinghaus JW. Fire-air and dephlogistication. Revisionisms of oxygen's discovery. Adv Exp Med Biol 2003; 543: 7-19.
2. Sternbach GL, Varon J. The discovery and rediscovery of oxygen. J Emerg Med 2005; 28: 221-224.
3. Stofft H. New born's apparent death (1781-1806) through Francois Chaussier's Work. Hist Sci Med 1997; 31: 341-349.
4. Raju TN. The Nobel chronicles. 1949: Walter Rudolf Hess (1881-1973); and Antonio Egas Moniz (1874-1955). Lancet 1999; 353: 1281.
5. Robertson AF, Baker JP. Lessons from the past. Semin Fetal Neonatal Med 2005; 10: 23-30.
6. Terry TL. Retrolental fibroplasia in the premature infant: V. Further studies on fibroplastic overgrowth of the persistent tunica vasculosa lentis. Trans Am Ophthalmol Soc 1944; 42: 383-396.
7. Campbell K. Intensive oxygen therapy as a possible cause of retrolental fibroplasia: a clinical approach. Med J Aust 1951; 2: 48-50.
8. Noguera-Palau JJ. Stevie Wonder. Saginaw (USA), 1950. Arch Soc Esp Oftalmol 2008; 83: 281.
9. Patz A, Hoeck LE, De La Cruz E. Studies on the effect of high oxygen administration in retrolental fibroplasia. I. Nursery observations. Am J Ophthalmol 1952; 35: 1248-1253.
10. Kinsey VE, Arnold HJ, Kalina RE, Stern L, Stahlman M, Odell G, et al. PaO2 levels and retrolental fibroplasia: a report of the cooperative study. Pediatrics 1977; 60: 655-668.
11. Usher RH. Clinical investigation of the respiratory distress syndrome of prematurity. Interim report. N Y State J Med 1961; 61: 1677-1696.
12. Flynn JT, Bancalari E, Snyder ES, Goldberg RN, Feuer W, Cassady J, et al. A cohort study of transcutaneous oxygen tension and the incidence and severity of retinopathy of prematurity. N Engl J Med 1992; 326: 1050-1054.
13. Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes. Pediatrics 2000; 105: 295-310.
14. Askie LM, Henderson-Smart DJ, Irwig L, Simpson JM. Oxygen-saturation targets and outcomes in extremely preterm infants. N Engl J Med 2003; 349: 959-967.
15. Hua SD, Chen YQ, Dong JY, Kong XY, Feng ZC. Screening and risk factors analysis of retinopathy of prematurity. Chin J Pediatr (Chin) 2009; 47: 757-761.
16. Dawson JA, Kamlin CO, Vento M, Wong C, Cole TJ, Donath SM, et al. Defining the reference range for oxygen saturation for infants after birth. Pediatrics 2010; 125: e1340-e1347.
17. Wright CJ, Zhuang T, La P, Yang G, Dennery PA. Hyperoxia-induced NF-kappaB activation occurs via a maturationally sensitive atypical pathway. Am J Physiol Lung Cell Mol Physiol 2009; 296: L296-L306.
18. Yang G, Abate A, George AG, Weng YH, Dennery PA. Maturational differences in lung NF-kappaB activation and their role in tolerance to hyperoxia. J Clin Invest 2004; 114: 669-678.
19. Lee PJ, Camhi SL, Chin BY, Alam J, Choi AM. AP-1 and STAT mediate hyperoxia-induced gene transcription of heme oxygenase-1. Am J Physiol Lung Cell Mol Physiol 2000; 279: L175-L182.
20. Yang G, Madan A, Dennery PA. Maturational differences in hyperoxic AP-1 activation in rat lung. Am J Physiol Lung Cell Mol Physiol 2000; 278: L393-L938.
21. Maniscalco WM, Watkins RH, Roper JM, Staversky R, O'Reilly MA. Hyperoxic ventilated premature baboons have increased p53, oxidant DNA damage and decreased VEGF expression. Pediatr Res 2005; 58: 549-556.
22. Michiels C, Minet E, Mottet D, Raes M. Regulation of gene expression by oxygen: NF-kappaB and HIF-1, two extremes. Free Radic Biol Med 2002; 33: 1231-1342.
23. Wright CJ, Dennery PA. Manipulation of gene expression by oxygen: a primer from bedside to bench. Pediatr Res 2009; 66: 3-10.
24. Chandel NS, Budinger GR. The cellular basis for diverse responses to oxygen. Free Radic Biol Med 2007; 42: 165-74.
25. Bunn HF, Poyton RO. Oxygen sensing and molecular adaptation to hypoxia. Physiol Rev 1996; 76: 839-85.
26. de Lamirande E, Gagnon C. Reactive oxygen species (ROS) and reproduction. Adv Exp Med Biol 1994; 366: 185-197.
27. Bize I, Santander G, Cabello P, Driscoll D, Sharpe C. Hydrogen peroxide is involved in hamster sperm capacitation in vitro. Biol Reprod 1991; 44: 398-403.
28. de Lamirande E, Gagnon C. Impact of reactive oxygen species on spermatozoa: a balancing act between beneficial and detrimental effects. Hum Reprod 1995; 10 Suppl 1: 15-21.
29. Pierce GB, Parchment RE, Lewellyn AL. Hydrogen peroxide as a mediator of programmed cell death in the blastocyst. Differentiation 1991; 46: 181-186.
30. Salas-Vidal E, Lomeli H, Castro-Obregon S, Cuervo R, Escalante-Alcalde D, Covarrubias L. Reactive oxygen species participate in the control of mouse embryonic cell death. Exp Cell Res 1998; 238: 136-147.
31. Groner Y, Elroy-Stein O, Avraham KB, Schickler M, Knobler H, Minc-Golomb D, et al. Cell damage by excess CuZnSOD and Down's syndrome. Biomed Pharmacother 1994; 48: 231-240.
32. Shin JH, London J, Le Pecheur M, Hoger H, Pollak D, Lubec G. Aberrant neuronal and mitochondrial proteins in hippocampus of transgenic mice overexpressing human Cu/Zn superoxide dismutase 1. Free Radic Biol Med 2004; 37: 643-653.
33. Frank L. Developmental aspects of experimental pulmonary oxygen toxicity. Free Radic Biol Med 1991; 11: 463-494.
34. Dennery PA. Role of redox in fetal development and neonatal diseases. Antioxid Redox Signal 2004; 6: 147-153.
35. Chen J, Smith LE. Retinopathy of prematurity. Angiogenesis 2007; 10: 133-140.
36. Crapo JD. Morphologic changes in pulmonary oxygen toxicity. Annu Rev Physiol 1986; 48: 721-31.
37. Warner BB, Stuart LA, Papes RA, Wispe JR. Functional and pathological effects of prolonged hyperoxia in neonatal mice. Am J Physiol 1998; 275(1 Pt 1): L110-L117.
38. Martin RJ, Bookatz GB, Gelfand SL, Sastre J, Arduini A, Aguar M, et al. Consequences of neonatal resuscitation with supplemental oxygen. Semin Perinatol 2008; 32: 355-366.
39. Fujinaga H, Baker CD, Ryan SL, Markham NE, Seedorf GJ, Balasubramaniam V, et al. Hyperoxia disrupts vascular endothelial growth factor-nitric oxide signaling and decreases growth of endothelial colony-forming cells from preterm infants. Am J Physiol Lung Cell Mol Physiol 2009; 297: L1160-L1169.
40. Lakshminrusimha S, Swartz DD, Gugino SF, Ma CX, Wynn KA, Ryan RM, et al. Oxygen concentration and pulmonary hemodynamics in newborn lambs with pulmonary hypertension. Pediatr Res 2009; 66: 539-544.
41. Solas AB, Kalous P, Saugstad OD. Reoxygenation with 100 or 21% oxygen after cerebral hypoxemia-ischemia-hypercapnia in newborn piglets. Biol Neonate 2004; 85: 105-111.
42. Saugstad OD, Ramji S, Irani SF, El-Meneza S, Hernandez EA, Vento M, et al. Resuscitation of newborn infants with 21% or 100% oxygen: follow-up at 18 to 24 months. Pediatrics 2003; 112: 296-300.
43. Finer NN, Carlo WA, Walsh MC, Rich W, Gantz MG, Laptook AR, et al. Early CPAP versus surfactant in extremely preterm infants. N Engl J Med 2010; 362: 1970-1979.
44. Spector LG, Klebanoff MA, Feusner JH, Georgieff MK, Ross JA. Childhood cancer following neonatal oxygen supplementation. J Pediatr 2005; 147: 27-31.
45. Cnattingius S, Zack MM, Ekbom A, Gunnarskog J, Kreuger A, Linet M, et al. Prenatal and neonatal risk factors for childhood lymphatic leukemia. J Natl Cancer Inst 1995; 87: 908-914.
46. Sanchez ME, Andrews BJ, Karr D, Lansingh V, Winthrop KL. The emergence of retinopathy of prematurity in Guatemala. J Pediatr Ophthalmol Strabismus 2009; 8: 1-4.
47. Munoz B, West SK. Blindness and visual impairment in the Americas and the Caribbean. Br J Ophthalmol 2002; 86: 498-504.
48. Gilbert C, Rahi J, Eckstein M, O'Sullivan J, Foster A. Retinopathy of prematurity in middle-income countries. Lancet 1997; 350: 12-14.